Dr. Adeel Khan

And what I believe is a solution is personally, you know, if our company becomes big enough, I'm going to get some regenerative medicine lobbyists. And you bet you I'm going to get them to start lobbying for us, because I think that's the only way to really get this stuff moving in the U.S.

And what I believe is a solution is personally, you know, if our company becomes big enough, I'm going to get some regenerative medicine lobbyists. And you bet you I'm going to get them to start lobbying for us, because I think that's the only way to really get this stuff moving in the U.S.

Well, no, it's not a problem, right? Like I, that company I was just talking about, for example, a 3d bioprinting company, they got, they got a mask national NIH grant.

Well, no, it's not a problem, right? Like I, that company I was just talking about, for example, a 3d bioprinting company, they got, they got a mask national NIH grant.

know for 18 million dollars they're able to do some uh animal studies and some preliminary phase one stuff but now they're hitting a roadblock because obviously they have to they need more money to do more trials and it's so expensive to do clinical trials in the us that you and they can't get any more money from nih so basically they have to go to dc's venture capital or private equity and try to raise money and they're having they can't get it it's like too hard because they're biotech and it's high risk and

know for 18 million dollars they're able to do some uh animal studies and some preliminary phase one stuff but now they're hitting a roadblock because obviously they have to they need more money to do more trials and it's so expensive to do clinical trials in the us that you and they can't get any more money from nih so basically they have to go to dc's venture capital or private equity and try to raise money and they're having they can't get it it's like too hard because they're biotech and it's high risk and

Yada, yada, yada.

Yada, yada, yada.

And so it's really hard for these regenerative medicine companies to fund and find money and to, and honestly, that's, that's actually been my strength is I'm good at finding technology and I have, I have a good networks and I'm able to help like the new cells, for example, Professor Gisela, unfortunately hasn't had the, you know, she, she, she had funding, but then lost her funding because again, politics and,

And so it's really hard for these regenerative medicine companies to fund and find money and to, and honestly, that's, that's actually been my strength is I'm good at finding technology and I have, I have a good networks and I'm able to help like the new cells, for example, Professor Gisela, unfortunately hasn't had the, you know, she, she, she had funding, but then lost her funding because again, politics and,

But I'm able to, you know, help her with that stuff. And I have and then obviously I have marketing and other resources.

But I'm able to, you know, help her with that stuff. And I have and then obviously I have marketing and other resources.

And so we can and that's that's kind of my, I guess, vision with this stuff is being able to actually drive this stuff forward by doing the controlled clinical trials of very promising technologies that I believe that, you know, based off the science, I think are going to be a huge part of the future of medicine.

And so we can and that's that's kind of my, I guess, vision with this stuff is being able to actually drive this stuff forward by doing the controlled clinical trials of very promising technologies that I believe that, you know, based off the science, I think are going to be a huge part of the future of medicine.

Uh, funny enough, because alternative media is becoming more and more popular. And I think people will demand. that their doctors or people know that, Hey, look, I deserve to have this as an option, you know? And I think that's what it comes down to. Patients have the right to have all their options explored and especially options that are safe and can be just as effective as surgery.

Uh, funny enough, because alternative media is becoming more and more popular. And I think people will demand. that their doctors or people know that, Hey, look, I deserve to have this as an option, you know? And I think that's what it comes down to. Patients have the right to have all their options explored and especially options that are safe and can be just as effective as surgery.

So I think it's, it's, you know, it's unfair to patients to not be able to, or the doctors to not even know anything about this stuff and not be able to have a conversation with their patient about it just because they don't know. Unfortunately, they don't know anything about regenerative medicine. And just because, I mean, you and me didn't learn anything about legitimacy in that school, right?

So I think it's, it's, you know, it's unfair to patients to not be able to, or the doctors to not even know anything about this stuff and not be able to have a conversation with their patient about it just because they don't know. Unfortunately, they don't know anything about regenerative medicine. And just because, I mean, you and me didn't learn anything about legitimacy in that school, right?

So there was no education.

So there was no education.